1.61
                                            Schlusskurs vom Vortag:
              $1.54
            Offen:
              $1.54
            24-Stunden-Volumen:
                757.63K
            Relative Volume:
              0.90
            Marktkapitalisierung:
                $171.64M
            Einnahmen:
              $45.44M
            Nettoeinkommen (Verlust:
              $-35.43M
            KGV:
              -4.7353
            EPS:
                -0.34
            Netto-Cashflow:
                $-25.39M
            1W Leistung:
              +4.55%
            1M Leistung:
              -5.85%
            6M Leistung:
                -42.91%
            1J Leistung:
              -57.29%
            Maxcyte Inc Stock (MXCT) Company Profile
Firmenname
                  
                      Maxcyte Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      301-517-5556
                    
                Adresse
                  
                      9713 KEY WEST AVENUE,, ROCKVILLE
                    
                Vergleichen Sie MXCT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                MXCT
                            
                             
                        Maxcyte Inc 
                           | 
                    1.61 | 164.17M | 45.44M | -35.43M | -25.39M | -0.34 | 
| 
                         
                          
                                ABT
                            
                             
                        Abbott Laboratories 
                           | 
                    123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 | 
| 
                         
                          
                                BSX
                            
                             
                        Boston Scientific Corp 
                           | 
                    98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 | 
| 
                         
                          
                                SYK
                            
                             
                        Stryker Corp 
                           | 
                    358.16 | 136.23B | 24.38B | 2.94B | 4.07B | 7.6159 | 
| 
                         
                          
                                MDT
                            
                             
                        Medtronic Plc 
                           | 
                    90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 | 
| 
                         
                          
                                EW
                            
                             
                        Edwards Lifesciences Corp 
                           | 
                    83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 | 
Maxcyte Inc Stock (MXCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-08-11 | Herabstufung | BTIG Research | Buy → Neutral | 
| 2025-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform | 
| 2025-07-22 | Eingeleitet | Stephens | Overweight | 
| 2023-11-29 | Eingeleitet | Craig Hallum | Buy | 
| 2021-10-15 | Fortgesetzt | Cowen | Outperform | 
| 2021-08-24 | Eingeleitet | BTIG Research | Buy | 
| 2021-08-24 | Eingeleitet | Cowen | Outperform | 
| 2021-08-24 | Eingeleitet | Stephens | Overweight | 
| 2021-08-24 | Eingeleitet | Stifel | Buy | 
| 2021-08-24 | Eingeleitet | Wedbush | Outperform | 
| 2021-08-24 | Eingeleitet | William Blair | Outperform | 
                    Alle ansehen
                    
                  
                Maxcyte Inc Aktie (MXCT) Neueste Nachrichten
MaxCyte Inc expected to post a loss of 11 cents a shareEarnings Preview - TradingView
What Wall Street predicts for MaxCyte Inc. stock priceWeekly Profit Analysis & Stock Portfolio Risk Management - newser.com
Reversal indicators forming on MaxCyte Inc. stockGap Up & Free Expert Approved Momentum Trade Ideas - newser.com
Can MaxCyte Inc. (MYE0) stock stage a strong rebound this quarterPortfolio Return Summary & Precise Entry and Exit Recommendations - newser.com
Real time scanner hits for MaxCyte Inc. explained2025 Risk Factors & AI Powered Market Entry Strategies - newser.com
Technical analysis overview for MaxCyte Inc. stock2025 Technical Overview & High Accuracy Trade Alerts - newser.com
Will MaxCyte Inc. (MYE0) stock outperform benchmarksGlobal Markets & Entry Point Confirmation Signals - newser.com
What MACD signals say about MaxCyte Inc.July 2025 Breakouts & Fast Gain Swing Alerts - newser.com
Why MaxCyte Inc. stock could outperform in 2025Trade Signal Summary & Real-Time Volume Triggers - newser.com
Will MaxCyte Inc. (MYE0) stock see valuation expansion2025 AllTime Highs & Consistent Return Investment Signals - newser.com
Backtesting results for MaxCyte Inc. trading strategiesWeekly Trade Recap & Fast Entry Momentum Trade Alerts - newser.com
Statistical indicators supporting MaxCyte Inc.’s strengthJuly 2025 PreEarnings & Real-Time Volume Trigger Notifications - newser.com
Is MaxCyte Inc. stock a buy in volatile marketsJuly 2025 Trade Ideas & Real-Time Market Sentiment Alerts - newser.com
Can MaxCyte Inc. stock deliver strong Q4 earningsMarket Rally & Entry Point Confirmation Alerts - newser.com
Will breakout in MaxCyte Inc. lead to full recoveryEntry Point & Fast Moving Market Watchlists - newser.com
Why MaxCyte Inc. stock remains a top recommendation2025 Support & Resistance & Fast Entry Momentum Trade Alerts - newser.com
How to interpret RSI for MaxCyte Inc. stock2025 Big Picture & Growth Oriented Trade Recommendations - newser.com
How buyback programs support MaxCyte Inc. (MYE0) stockDay Trade & AI Enhanced Execution Alerts - newser.com
Can MaxCyte Inc. stock resist market sell offsQuarterly Earnings Report & Verified Trade Idea Suggestions - newser.com
MaxCyte (MXCT) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
MaxCyte, Inc. (NASDAQ:MXCT) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Finanzdaten der Maxcyte Inc-Aktie (MXCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):